Literature DB >> 21605113

Incidental CD8 T cell reactivity against caspase-cleaved apoptotic self-antigens from ubiquitously expressed proteins in islets from prediabetic human leucocyte antigen-A2 transgenic non-obese diabetic mice.

K T Coppieters1, N Amirian, M G von Herrath.   

Abstract

Apoptosis is known as a major mechanism which contributes to beta cell decay in type 1 diabetes. Commitment to this pathway generally involves caspase-mediated protein cleavage and was found to induce cross-presentation of a specific antigen repertoire under certain inflammatory conditions. We aimed to assess the significance of the CD8 T cell population reactive against such caspase-cleaved apoptotic self-antigens in pancreatic islets of prediabetic human leucocyte antigen (HLA)-A2 transgenic non-obese diabetic chimeric monochain transgene construct (NOD.HHD) mice. We have reproduced a unique peptide library consisting of human CD8 T cell-derived apoptosis-specific antigens, all of which belong to structural proteins expressed ubiquitously in human islets. Pancreatic islets from prediabetic NOD.HHD mice, harbouring humanized major histocompatibilty complex (MHC) class I, were isolated and handpicked at various ages, and islet-infiltrating CD8 T cells were expanded in vitro and used as responders in an interferon (IFN)-γ enzyme-linked immunospot (ELISPOT) assay. Human T2 cells were used as antigen-presenting cells (APC) to avoid endogenous antigen presentation. Analogous to the interindividual variability found with peptides from known islet autoantigens such as islet-specific glucose-6-phosphatase catalytic subunit related protein (IGRP) and insulin, some mice showed variable, low-degree CD8 T cell reactivity against caspase-cleaved self-antigens. Because reactivity was predominantly minor and often undetectable, we conclude that beta cell apoptosis does not routinely provoke the development of dominant cytotoxic T lymphocyte (CTL) reactive against caspase-cleaved self-antigens in the NOD.HHD model.
© 2011 The Authors. Clinical and Experimental Immunology © 2011 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21605113      PMCID: PMC3142640          DOI: 10.1111/j.1365-2249.2011.04420.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

1.  Apoptotic cells overexpress vinculin and induce vinculin-specific cytotoxic T-cell cross-priming.

Authors:  A Propato; G Cutrona; V Francavilla; M Ulivi; E Schiaffella; O Landt; R Dunbar; V Cerundolo; M Ferrarini; V Barnaba
Journal:  Nat Med       Date:  2001-07       Impact factor: 53.440

2.  Coding sequence and flanking regions of the mouse vimentin gene.

Authors:  H Hennekes; S Kühn; P Traub
Journal:  Mol Gen Genet       Date:  1990-03

3.  Human clonal CD8 autoreactivity to an IGRP islet epitope shared between mice and men.

Authors:  W W J Unger; G G M Pinkse; S Mulder-van der Kracht; A R van der Slik; M G D Kester; F Ossendorp; J W Drijfhout; D V Serreze; B O Roep
Journal:  Ann N Y Acad Sci       Date:  2007-03-21       Impact factor: 5.691

4.  Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes.

Authors:  Gabrielle G M Pinkse; Odette H M Tysma; Cees A M Bergen; Michel G D Kester; Ferry Ossendorp; Peter A van Veelen; Bart Keymeulen; Danny Pipeleers; Jan W Drijfhout; Bart O Roep
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-09       Impact factor: 11.205

5.  Identification of a beta-cell-specific HLA class I restricted epitope in type 1 diabetes.

Authors:  Constadina Panagiotopoulos; Huilian Qin; Rusung Tan; C Bruce Verchere
Journal:  Diabetes       Date:  2003-11       Impact factor: 9.461

Review 6.  Translational mini-review series on type 1 diabetes: Immune-based therapeutic approaches for type 1 diabetes.

Authors:  T Staeva-Vieira; M Peakman; M von Herrath
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

7.  Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetes.

Authors:  S Marin-Gallen; X Clemente-Casares; R Planas; I Pujol-Autonell; J Carrascal; J Carrillo; R Ampudia; J Verdaguer; R Pujol-Borrell; F E Borràs; M Vives-Pi
Journal:  Clin Exp Immunol       Date:  2009-12-17       Impact factor: 4.330

8.  Novel packages of viral and self-antigens are generated during apoptosis.

Authors:  A Rosen; L Casciola-Rosen; J Ahearn
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

9.  Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells.

Authors:  B Sauter; M L Albert; L Francisco; M Larsson; S Somersan; N Bhardwaj
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

10.  Systemic exposure to irradiated apoptotic cells induces autoantibody production.

Authors:  D Mevorach; J L Zhou; X Song; K B Elkon
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

View more
  5 in total

Review 1.  Clinical potential of antigen-specific therapies in type 1 diabetes.

Authors:  Ken T Coppieters; Birgit Sehested Hansen; Matthias G von Herrath
Journal:  Rev Diabet Stud       Date:  2012-12-28

Review 2.  Immunology in the clinic review series: focus on type 1 diabetes and viruses: the role of viruses in type 1 diabetes: a difficult dilemma.

Authors:  K T Coppieters; A Wiberg; S M Tracy; M G von Herrath
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

Review 3.  Trials in type 1 diabetes: Antigen-specific therapies.

Authors:  Ken T Coppieters; Leonard C Harrison; Matthias G von Herrath
Journal:  Clin Immunol       Date:  2013-02-15       Impact factor: 3.969

Review 4.  Progress in immune-based therapies for type 1 diabetes.

Authors:  M von Herrath; M Peakman; B Roep
Journal:  Clin Exp Immunol       Date:  2013-05       Impact factor: 4.330

5.  CD8+ T Cells Specific to Apoptosis-Associated Antigens Predict the Response to Tumor Necrosis Factor Inhibitor Therapy in Rheumatoid Arthritis.

Authors:  Alessandra Citro; Rossana Scrivo; Helene Martini; Carmela Martire; Paolo De Marzio; Anna Rita Vestri; John Sidney; Alessandro Sette; Vincenzo Barnaba; Guido Valesini
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.